IP Library › Assignment 057394/0812
Patent Assignment
Reel/Frame 057394/0812

Change of Name

Recorded: 2021-08-31 Pages: 31
Assignor
ARCUTIS, INC.
Executed: 2019-10-08
Assignee
ARCUTIS BIOTHERAPEUTICS, INC.
3027 TOWNSGATE ROAD, #300, WESTLAKE VILLAGE, CALIFORNIA, 91361
Covered Properties (6)
Inhibition of Crystal Growth of Roflumilast
Patent: 9,895,359 →
Application: 15/616,409 →
Inhibition of Crystal Growth of Roflumilast
Patent: 9,884,050 →
Application: 15/676,356 →
Inhibition of Crystal Growth of Roflumilast
Patent: 9,907,788 →
Application: 15/676,373 →
Inhibition of Crystal Growth of Roflumilast
Application: 15/848,462 →
Publication: US 2018/0353490
Inhibition of Crystal Growth of Roflumilast
Application: 15/848,505 →
Inhibition of Crystal Growth of Roflumilast
Application: 16/136,804 →
Publication: US 2019/0015398
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 7, 2017
From: OSBORNE, DAVID W.
To: ARCUTIS, INC.
Reel/Frame 042638/0206 →
Security Interest Dec 22, 2021
From: ARCUTIS BIOTHERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 058463/0187 →
Assignment of Assignor's Interest Feb 26, 2024
From: OSBORNE, DAVID W.
To: ARCUTIS, INC.
Reel/Frame 066560/0442 →
Assignment of Assignor's Interest Jul 3, 2024
From: OSBORNE, DAVID W.
To: ARCUTIS, INC.
Reel/Frame 068122/0061 →
Assignment of Assignor's Interest Jul 5, 2024
From: OSBORNE, DAVID W.
To: ARCUTIS, INC.
Reel/Frame 068133/0720 →